Skip to main content
Signal8

Autolus Therapeutics plc (AUTL)

Autolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for various oncological conditions. The company's pipeline includes several investigational programs: obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell therapy, is currently undergoing Phase 1b/2 trials for adult acute lymphoblastic leukemia (ALL). Additionally, AUTO1/22 is in a Phase 1 study for pediatric patients experiencing relapsed or refractory ALL. Autolus is also advancing AUTO4, a programmed T cell therapy designed to target TRBC1 for the treatment of peripheral T-cell lymphoma, and AUTO8, a product candidate currently in Phase I clinical trials for multiple myeloma. In earlier development, AUTO6NG, a programmed T cell therapy, is in preclinical research targeting GD2 for neuroblastoma, and AUTO5 is another hematological product candidate in its preclinical stages. Established in 2014, Autolus Therapeutics maintains its headquarters in London, United Kingdom.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Autolus Therapeutics plc logo

Autolus Therapeutics plc

NASDAQ:AUTLHealthcare
-3.80%$1.52
AH$1.51-0.62%vs close
Mkt Cap$404.57M
Float218.05M
O/S266.16M
Vol
$ Vol
RVOL
Inst Own49.7%
SI4.2%
Earnings
Dilution
Financials Summary
Revenue$75.56M
Net Income-$288.2M
Total Assets$589.07M
Free Cash Flow-$310.7M
Debt & Equity
Debt 66%
Equity 34%
Total Debt$351.59M
Total Equity$178.13M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in AUTL's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$589.07M
Liabilities$410.94M
Accounts Receivable$75.79M
Accounts Payable$3.08M
Inventory$33.21M
PP&E (Net)$128.5M
Goodwill$0
Intangible Assets$19.81M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-302015-09-30
Revenue$75.56M$10.12M$1.7M$6.19M$1.51M$1.72M$2.91M$1.05M$1.69M$1.21M$94K
YoY Growth646.7%496.0%-72.6%311.0%-12.1%-41.0%178.2%-38.3%39.7%1187.8%-
Cost of Revenue$96.59M$141.02M$0$0$0$134.89M$105.42M$48.3M$1.01M$478K$0
Gross Profit-$21.03M-$130.9M$1.7M$6.19M$1.51M-$133.17M-$102.51M-$47.25M$684K$734K$94K
Gross Margin-27.8%-1293.5%100.0%100.0%100.0%-7765.2%-3525.1%-4520.4%40.4%60.6%100.0%
Research and Development$128.59M$158.14M$130.48M$117.35M$110.84M$134.99M$105.62M$24.64M$16.01M$10.44M$2.17M
Selling, General, and Administrative$131.82M$0$46.74M$31.9M$31.86M$34.97M$39.45M$16.85M$9.1M$5.15M$6.04M
Other$0-$47.61M$4.17M-$166K-$823K$0$0$3.97M-$46K-$26K$0
Total Operating Expenses$260.41M$110.53M$181.4M$149.09M$141.88M$169.96M$145.07M$41.48M$25.11M$15.59M$8.2M
Operating Income (EBIT)-$281.44M-$241.43M-$179.7M-$142.89M-$140.37M-$303.13M-$247.58M-$57.53M-$23.42M-$14.38M-$8.11M
Operating Margin-372.4%-2385.6%-10583.1%-2307.0%-9314.8%-17675.4%-8513.8%-5503.7%-1383.2%-1186.1%-8613.8%
Interest Expense$36.76M$9.29M$45.07M$8.9M$1.1M$0$0$13K$0$0$0
Interest Income$19.02M$32.35M$13.51M$1.71M$262K$536K$2.54M$4.12M$84K$75K$8K
Other Income (Expense)-$15.41M$22.29M-$28.7M-$5.67M-$1.66M$136.88M$138.89M$6.91M$38K$49K$8K
Income Before Tax (EBT)-$296.85M-$219.13M-$208.4M-$148.57M-$142.04M-$166.26M-$108.69M-$36.33M-$23.38M-$14.33M-$8.1M
Income Tax Expense-$8.65M$1.53M-$19K$272K$58K-$24.16M$15.16M-$5.21M-$3.65M-$1.78M-$635K
Net Income-$288.2M-$220.66M-$208.38M-$148.84M-$142.1M-$142.09M-$123.85M-$31.11M-$19.73M-$12.55M-$7.46M
Net Income Margin-381.4%-2180.5%-12272.3%-2403.0%-9429.1%-8285.4%-4258.9%-2976.5%-1165.2%-1035.5%-7931.1%
Supplementary Data
EPS-1.08-0.87-1.20-1.57-1.97-2.76-2.88-0.99-1.43-0.91-0.54
Diluted EPS-1.08-0.87-1.20-1.57-1.97-2.76-2.88-0.99-1.43-0.91-0.54
Weighted Average OS266.14M255.16M173.94M94.99M72.08M51.56M43.07M31.56M13.78M13.78M13.78M
EBITDA-$250.28M-$233.07M-$156.77M-$132.24M-$132.47M-$162.49M-$137.35M-$50.32M-$22.41M-$13.9M-$4.47M
EBITDA Margin-331.2%-2303.1%-9232.6%-2135.0%-8790.6%-9474.5%-4723.2%-4813.9%-1323.6%-1146.7%-4749.8%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-302015-09-30
Assets
Current Assets
Cash and Cash Equivalents$104.13M$227.38M$239.57M$382.44M$310.34M$154.09M$211.43M$189.3M$137.07M$28.06M$10.18M
Short-Term Investments$196.58M$360.64M$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$300.71M$588.02M$239.57M$382.44M$310.34M$154.09M$211.43M$189.3M$137.07M$28.06M$10.18M
Accounts Receivable$75.79M$48.24M$1.05M$28.98M$68K$29.68M$30.52M$9.26M$4.73M$2.18M$0
Inventory$33.21M$4.14M$0$0$0$0$0$2.21M$0$0$0
Other Current Assets$4.93M$5.32M$26.05M$2.02M$27.83M$0$279K$717K$0$0$1.15M
Total Current Assets$435.92M$660.93M$275.3M$425.77M$346.95M$193.98M$249.26M$199.14M$142.48M$30.93M$11.49M
Long-Term Assets
Property, Plant & Equipment Net$128.5M$105.05M$95.65M$58.42M$52.32M$89.68M$51.57M$9.22M$6.18M$3.25M$916K
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$19.81M$12.37M$0$0$65K$158K$254K$9.29M$0$9.5M$10.24M
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$3.56M$3.24M$3.06M$2.08M$0$1.75M$410K$0$0$0$0
Other Long-Term Assets$1.28M$1.13M$1.36M$4.01M$6.23M$8.67M$2.04M$0$0-$9.5M$0
Total Long-Term Assets$153.15M$121.8M$100.08M$64.5M$58.61M$100.26M$54.28M$18.51M$6.18M$3.25M$11.16M
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$589.07M$782.73M$375.38M$490.27M$405.56M$294.24M$303.53M$217.66M$148.66M$34.18M$22.66M
Liabilities
Current Liabilities
Accounts Payable$3.08M$1.97M$103K$531K$431K$2.26M$0$3.04M$1.95M$1.44M$1.69M
Short-Term Debt$14.56M$0$0$0$0$3.59M$2.51M$0$0$0$0
Current Income Tax Payable$0$3.59M$0$0$0$0$391K$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$569K$197K$53K$0
Other Current Liabilities$55.79M$23.66M$15.29M$10.57M$160K$19.05M$15.51M$11.03M$589K$1.3M$259K
Total Current Liabilities$73.44M$60.74M$44.74M$46.37M$28.55M$33.63M$24.98M$12.52M$5.03M$2.73M$1.95M
Long-Term Liabilities
Long-Term Debt$270.2M$0$0$0$47.02M$0$0$221K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$477K$245.03M$171.26M$126.02M$128K$0$0$159K$763K$570K$0
Total Long-Term Liabilities$337.5M$294.66M$219.17M$145.23M$63.69M$50.57M$23.71M$601K$1.03M$758K$0
Other Liabilities$0$0$0$0$0$0$0-$601K$0$0$0
Total Liabilities$410.94M$355.4M$263.91M$191.6M$92.24M$84.2M$48.69M$12.52M$6.06M$3.49M$1.95M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$1K$0$0
Common Stock$12K$12K$8K$8K$4K$121K$120K$1K$1K$577$322
Retained Earnings-$1.39B-$1.1B-$878.56M-$670.18M-$521.34M-$379.24M-$237.15M$163.84M-$47.9M-$28.18M-$9.33M
Comprehensive Income & Other-$5.36M-$29.17M-$28.99M-$38.9M-$8.45M-$5.86M-$8.69M-$76.27M-$3.85M-$4.65M$0
Other Stockholders' Equity$1.56B$1.53B$990.03M$968.85M$834.66M$589.15M$491.87M$41.3M$190.5M$58.86M$30.04M
Total Equity$178.13M$427.32M$111.47M$298.67M$313.32M$210.03M$254.84M$205.14M$142.6M$30.69M$20.71M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$589.07M$782.73M$375.38M$490.27M$405.56M$294.24M$303.53M$217.66M$148.66M$34.18M$22.66M
Supplementary Data
Total Debt$351.59M$52.63M$52.97M$24.26M$68.01M$54.16M$26.22M$221K$265K$188K$0
Net Debt$247.45M-$174.75M-$186.6M-$358.18M-$242.32M-$99.92M-$185.21M-$189.08M-$136.81M-$27.87M-$10.18M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-302015-09-30
Operating Activities
Net Income-$287.53M-$220.66M-$208.38M-$148.84M-$142.1M-$142.09M-$123.85M-$31.11M-$19.73M-$12.55M-$7.46M
Depreciation & Amortization$9.81M$7.72M$6.57M$7.42M$8.46M$5.66M$4.61M$1.71M$1.01M$478K$3.64M
Deferred Income Tax-$286K-$185K-$986K-$268K-$72K-$1.34M-$399K-$5.21M$0$0$0
Stock-Based Compensation$14.44M$15.47M$11.2M$12.01M$9.94M$20.11M$30.21M$5.03M$3.15M$2.26M$0
Changes in Working Capital:
  Accounts Receivable-$24.21M$0$0$0$0$0$0$0$0$0-$414K
  Inventory-$40.34M-$4.23M$0$0$0$0$0$0$0$0$0
  Accounts Payable$1.3M$1.59M-$509K$22K-$1.82M$1.44M-$1.45M$8.65M$434K$507K$0
  Other Working Capital$11.14M-$21.02M$801K$3.95M$5.95M-$29K-$14.75M-$3.23M-$1.23M-$1.74M$0
Total Working Capital Change-$52.11M-$23.66M$292K$3.97M$4.14M$1.41M-$16.2M$5.42M-$795K-$1.23M-$414K
Other Non-Cash Items$32.1M$15.04M$45.72M$13.39M$1.77M-$1.5M$4.14M-$1.68M$5.17M$1.2M$916K
Net Cash from Operating-$283.57M-$206.27M-$145.59M-$112.31M-$117.86M-$117.76M-$101.48M-$25.85M-$16.36M-$9.85M-$3.33M
Investing Activities
Capital Expenditures-$19.04M-$22.07M-$10.99M-$10.84M-$8.86M-$14.68M-$18.34M-$8.77M-$2.88M-$1.85M-$762K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$242.62M-$359.73M$0$0$0$0$0$0$0$0$0
Sales of Investments$428.21M$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$8.09M-$12.74M$0$0$0$0-$327K$1.13M$0$0$8K
Net Cash from Investing$158.46M-$394.55M-$10.99M-$10.84M-$8.86M-$14.68M-$18.67M-$7.65M-$2.88M-$1.85M-$754K
Financing Activities
Debt Repaid-----------
Common Stock Issuance$0$549.98M$0$163.85M$245.9M$79.75M$115.92M$128.7M$127.69M$32.22M$0
Common Stock Repurchases$0$0$0$0$0$0$0-$3.18M$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$4.34M$39.58M-$883K$59.76M$38.16M-$79.75M-$115.92M$0$0$0$12.23M
Net Cash from Financing-$4.34M$589.55M-$883K$223.61M$284.06M$74.42M$108.86M$117.49M$127.69M$32.22M$12.23M
Forex Effect$6.28M-$261K$15.03M-$28.38M-$754K$679K$5.16M$2.99M$561K-$2.66M$0
Net Change in Cash-$123.17M-$11.53M-$142.43M$72.08M$156.59M-$57.34M-$6.13M$86.98M$109.01M$17.86M$8.15M
Supplementary Data
Operating Cash Flow-$283.57M-$206.27M-$145.59M-$112.31M-$117.86M-$117.76M-$101.48M-$25.85M-$16.36M-$9.85M-$3.33M
Capital Expenditure-$27.13M-$34.82M-$10.99M-$10.84M-$8.86M-$14.68M-$18.67M-$8.77M-$2.88M-$1.85M-$762K
Free Cash Flow-$310.7M-$241.09M-$156.57M-$123.15M-$126.72M-$132.44M-$120.15M-$34.62M-$19.24M-$11.7M-$4.09M
Cash at Beginning$228.81M$240.34M$382.76M$310.68M$154.09M$211.43M$217.56M$102.32M$28.06M$10.2M$0
Cash at End$105.64M$228.81M$240.34M$382.76M$310.68M$154.09M$211.43M$189.3M$137.07M$28.06M$8.15M